Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 201 - 250 out of 32,255

Document Document Title
WO/2018/033642A1
The present invention relates to a compound of formula (I): wherein L is an optionally substituted heterocyclic group excluding unsubstituted monocyclic pyridine groups; wherein a is 0, 1 or 2; wherein R1 is H or with R2 is a bond; where...  
WO/2018/033642A9
The present invention relates to a compound of formula (I): wherein L is an optionally substituted heterocyclic group excluding unsubstituted monocyclic pyridine groups; wherein a is 0, 1 or 2; wherein R1 is H or with R2 is a bond; where...  
WO/2018/032356A1
A novel process for the preparation of lactone derivatives, and intermediates thereof is described. The lactone derivatives are important precursors for the synthesis of anti-hepatitis C virus agents, including sofosbuvir.  
WO/2018/033635A1
The invention relates to a process for the preparation of 2,2,5,5- tetramethyltetrahydrofuran (TMTHF) comprising contacting a TMTHF precursor with a solid catalyst, wherein the TMTHF precursor is 2,5-dimethylhexane-2,5-dioland/or 2,5-dim...  
WO/2018/033087A1
Disclosed are a compound using anthrone as a core and applications thereof. The compound uses anthrone as a parent core, which is connected to an aromatic heterocyclic group, so that the molecular symmetry is destroyed, the molecular cry...  
WO/2018/031853A1
Disclosed is an optical compensation film made of a solution cast of a polymer blend comprising a nitrated styrenic fluoropolymer and a polyimide. The compensation film is a positive-C plate having reversed wavelength dispersion that is ...  
WO/2018/029141A1
The invention relates to a method for producing 4-substituted 2,3-dihydro-1-benzofuran derivatives by cyclisation of 2-(2-diazonium-6-substituted phenyl)ethanol salts.  
WO/2018/029710A4
The present invention relates to the furanochalcone class of compounds of general formula A. The present invention particularly relates to the synthesis of furanochalcones and their CYP1A1, CYP1A2 and CYP1B1 inhibitory activity. In addit...  
WO/2018/029202A1
The invention relates to an anionic surfactant of general formula (I) in which n and m are, independently of one another, numbers from 0 to 17 and 2 < n + m < 20, and X+ is a charge-balancing cation. The invention also relates to a produ...  
WO/2018/028050A1
Disclosed is an asymmetric aryl-alkyl persulfate compound as represented by formula (3) and a synthesis method therefor, in which an arylboronic acid of formula (1) and R2SSCOR3 of formula (2) serve as reaction raw materials and, under t...  
WO/2018/029710A1
The present invention relates to the furanochalcone class of compounds of general formula A. The present invention particularly relates to the synthesis of furanochalcones and their CYP1A1, CYP1A2 and CYP1B1 inhibitory activity. In addit...  
WO/2018/031435A1
Herein are described chemotherapeutically active compositions that include a thermally activated saccharide. The thermally active saccharide (a chemotherapeutically active saccharide) can be selected from a thermally activated maltodextr...  
WO/2018/024188A1
Provided are a polycyclic compound and a manufacturing method, pharmaceutical composition, and application thereof. The structure of the polycyclic compound and an isomer, prodrug, solvate, hydrate, stable isotopic derivative, or pharmac...  
WO/2018/018863A1
Disclosed are a mild and efficient preparation method for an α-acyloxy alkenyl amide compound and a use thereof in the synthesis of an amide and a polypeptide. The α-acyloxy alkenyl amide compound is obtained by an addition reaction of...  
WO/2018/022848A1
A2-73 is a useful therapeutic in the treatment of humans suffering from insomnia, anxiety or agitation. Particular attention is made to oral daily doses of from about 10mg to about 50mg, with particular reference to about 20 to 30mg.  
WO/2018/019291A1
Provided is a method of synthesizing a C(sp3)-C(sp2) cross-coupled compound comprising reacting a C(sp3) coupling partner with a C(sp2) coupling partner, a catalyst, and a solvent; wherein the C(sp3) coupling partner comprises an organic...  
WO/2018/018091A1
The present invention relates to compounds and their use in the prophylactic and/or therapeutic treatment of pulmonary fibrosis and/or related conditions.  
WO/2018/017382A1
Disclosed is an oxidation process to produce a crude carboxylic acid product carboxylic acid product. The process comprises oxidizing a feed stream comprising at least one oxidizable compound to generate a crude carboxylic acid slurry co...  
WO/2018/017382A8
Disclosed is an oxidation process to produce a crude carboxylic acid product. The process comprises oxidizing a feed stream comprising at least one oxidizable compound to generate a crude carboxylic acid slurry comprising furan-2,5-dicar...  
WO/2018/016786A1
The present invention provides: a compound capable of implementing high luminous efficiency, a low driving voltage and improved lifespan of a device; an organic electronic device using the same; and an electronic apparatus thereof.  
WO/2018/016898A1
The present invention provides a novel heterocyclic compound and an organic light-emitting device using same.  
WO/2018/016742A1
The present invention provides a novel heterocyclic compound and an organic light-emitting device using same.  
WO/2018/018035A1
Prodrugs and derivatives of 5-hydoxymethyl-2-furfural (5-HMF) with protected or modified aldehyde and/or alcohol moieties are provided. The prodrugs or derivatives exhibit increased bioavailability, e.g. due to having extended half-lives...  
WO/2018/014834A1
Disclosed are a 3-hydrocarbyl-5,6-dioxy-substituted phthalide compound and a preparation method and use thereof. The structure of the phthalide compound is as shown in formula (I): wherein the definitions of R1, R2 and R3 are as describe...  
WO/2018/016724A1
The present invention relates to a compound for an organic optoelectronic device represented by chemical formula 1, a composition for an organic optoelectronic device, an organic optoelectronic device using the same, and a display device...  
WO/2018/017368A1
The inventive subject matter provides compounds, compositions and methods for lowering serum acid (sUA) for the treatment of gout, and having reduced liver toxicity, associated with CYP2C9 metabolic pathway.  
WO/2018/011673A3
The present disclosure relates to 1, 3, 5-dioxazine derivatives of formula (I) capable of reducing or eliminating hydrogen sulfide and other objectionable sulfides from oil field produced hydrocarbon fluids such as petroleum, fuel oil, g...  
WO/2018/012762A1
The present invention relates to a novel compound and an organic electroluminescent device comprising same. The compound, according to the present invention, can be used in an organic layer, preferably a light-emitting layer, of an organ...  
WO/2018/012426A1
Provided is a method for efficiently producing mucic acid from a commonly used organic raw material such as glucose or galactose. Provided is a method for producing mucic acid in which glucose or galactose is used as a starting material ...  
WO/2018/007764A1
The invention relates to a method for converting levoglucosenone into 4-hydroxymethyl butyrolactone and 4-hydroxymethyl butenolide without using any solvent or catalyst, wherein the oxidation and hydrolysis of the levoglucosenone or hydr...  
WO/2018/008737A1
The present invention addresses the problem of providing a compound which exerts its effect on the onset mechanism of Parkinson's disease by inhibiting the degeneration and cell death of dopamine-secreting cells, and a therapeutic or pro...  
WO/2018/008442A1
The purpose of the present invention is to provide: a π-conjugated compound exhibiting excellent light emission characteristics; an organic electroluminescent element using same; a display device; and an illumination device. Accordingly...  
WO/2018/007198A1
The present invention relates to the preparation of Thapsigargin (1) and Nortrilobolide (2). The invention further relates to intermediates and preparation of said intermediates which are useful for the preparation of (1) and (2).  
WO/2018/003968A1
The purpose of the present invention is to provide an industrial production method by which an ethylenically unsaturated group-containing γ-butyrolactone derivative is highly selectively obtained with use of a low-cost catalyst that is ...  
WO/2018/002291A1
The invention relates to a process for preparing 2,5-furandicarboxylic acid (FDCA) from furfuryl alcohol comprising: i) preparing 2,5-bis(hydroxymethyl)furan (BHMF) by hydroxymethylation of furfuryl alcohol by formaldehyde in aqueous sol...  
WO/2018/004095A1
The present invention relates to a compound, for an organic optoelectronic device, expressed by chemical formula (1), a composition for an organic optoelectronic device, an organic optoelectronic device having applied same, and a display...  
WO/2018/004315A2
The present specification relates to a compound of chemical formula 1 and an organic electronic element comprising the same.  
WO/2018/003945A1
[Problem] Provided are a method for producing 2-propanil 4-{(3S,5aR,6R,7R,8aS)-6-[(1E,3R)-4-(2,5-difluorophenoxy)-3-h ydroxy-1-butene-1-yl]-7-hydroxyoctahydro-2H-cyclopenta[b]oxe pine-3-yl}butanoate, which can solve various problems desc...  
WO/2018/003295A1
The present invention addresses the problem of providing: a 5-hydroxymethyl-2-furfural (5-HMF) production method which is suitable for the production of 5-hydroxymethyl-2-furfural (5-HMF) on an industrial scale; and a novel catalyst comp...  
WO/2018/004096A1
The present invention relates to a compound, for an organic optoelectronic device, expressed by chemical formula (1), a composition for an organic optoelectronic device, an organic optoelectronic device having applied same, and a display...  
WO/2018/004461A1
Disclosed herein is a catalyst composition that contains M0O3 supported on a carbonaceous material substrate, wherein MoO3 is present in an amount of from 2.0 wt% to 20.0 wt% of the composition and carbon is present in an amount of from ...  
WO/2018/004315A3
The present specification relates to a compound of chemical formula 1 and an organic electronic element comprising the same.  
WO/2018/004096A9
The present invention relates to a compound, for an organic optoelectronic device, expressed by chemical formula (1), a composition for an organic optoelectronic device, an organic optoelectronic device having applied same, and a display...  
WO/2017/222532A1
A process for the preparation of diastereomeric mono- and 2,5- bis(halomethyl)tetrahydrofurans from renewable THF-diols is described. Also disclosed are certain derivative compounds that can be prepared from the mono or di-alkyl halide f...  
WO/2017/220041A2
Disclosed are a bezafibrate pharmaceutical composition and an application thereof in rheumatoid arthritis. The bezafibrate pharmaceutical composition contains bezafibrate and a natural product compound (I) separated from dried clove buds...  
WO/2017/223151A1
The present disclosure provides a composition containing a sulfonamide aliphatic anhydride grafted olefin-based polymer. The present disclosure also provides a multilayer structure. In an embodiment, a multilayer film is provided and inc...  
WO/2017/223164A1
The present disclosure provides a process for producing an aliphatic sulfonyl azide anhydride and the resultant aliphatic sulfonyl azide anhydride composition. The process includes: (i) thio-acetoxylating an alkenyl carboxylic acid anhyd...  
WO/2017/222953A1
Disclosed are compounds that modulate the physiological action of the proprotein convertase subtilisin kexin type 9 (PCSK9), as well as therapeutic methods for use of such compounds to reduce LDL-cholesterol levels and/or for the treatme...  
WO/2017/220041A3
Disclosed are a bezafibrate pharmaceutical composition and an application thereof in rheumatoid arthritis. The bezafibrate pharmaceutical composition contains bezafibrate and a natural product compound (I) separated from dried clove buds...  
WO/2017/220042A2
Disclosed are an amrinone pharmaceutical composition and an application thereof in hypertension treatment. The amrinone pharmaceutical composition contains amrinone and a natural product compound (I) separated from dried blackberry lily ...  

Matches 201 - 250 out of 32,255